KLTO
Klotho Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.38
−7.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.28x
- Price / sales
- —
- Price / cash flow
- -4.08x
Enterprise value
- Enterprise value
- $15.3M
- EV / sales
- —
- EV / EBITDA
- -2.04x
- EV / EBIT
- -2.13x
- Market cap
- $22.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025